secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2022-05-10T23:59:59+00:00
Accession:  0000313143-22-000020
Event type: earnings
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics issues Q4 FY2022 earnings press release; details not available in filing text
--------------------------------------------------------------------------------

- Press release dated May 10, 2022, furnished as Exhibit 99.1, covers Q4 and full year ended April 2, 2022.
- Specific financial results (revenue, EPS, guidance) are not included in the 8-K or appended exhibit text provided.
- No material updates beyond the fact of the earnings release can be confirmed from the filing alone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000020/0000313143-22-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000020/hae-20220510.htm
  HTML page:      https://secwatch.observer/filing/0000313143-22-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer